- Exclusive
It's free video, simply login/signup to unlock
Get in-depth Industry Insights and Analysis through our “Exclusive” content, presented to you by our esteemed panel of writers, for free
By continuing, you agree to the T&C, Privacy Policy and Prohibited Content Policy. This same account can be used across all ET B2B portals.
India's Pharma Industry: Strategic Growth Driving Global Leadership
On the occasion of the 78th Independence Day, Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance (IPA), shared his insights with ETHealthworld's Prathiba Raju on the pivotal role of India's pharmaceutical industry in the nation's future and its potential to become a global healthcare leader. Valued at $58 billion with $19.5 billion in foreign exchange earnings, Jain envisions the industry reaching $120 billion by 2030 and $400 to $450 billion by 2047, with foreign exchange earnings soaring to $200 billion.
Watched by 2671 Industry Professionals
Watched by:
2671 Industry Professionals
Join the community of 2M+ industry professionals
Subscribe to our newsletter to get latest insights & analysis.
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions